Allergic Rhinitis Due to Weed Pollen
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
InimmuneINI-2004
InimmuneINI-2004
Clinical Trials (2)
Total enrollment: 146 patients across 2 trials
Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis
Start: Jan 2026Est. completion: Apr 202678 patients
Phase 2Completed
Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Start: Jul 2023Est. completion: Sep 202468 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.